&w=3840&q=100)
Crispy warning: How eating French fries can increase risk of diabetes
French fries are deep-fried in oils that often contain trans or saturated fats. Pixabay/Representational Image
Do you enjoy eating French fries? They are undoubtedly one of the most popular snacks around the world.
They are simple to prepare, need only a few ingredients, and take very little time to cook. Even though they are made using potatoes, the deep-frying process means they are not the healthiest choice.
Now, a new study has found that eating a certain amount of French fries each week could raise the chances of getting type 2 diabetes.
STORY CONTINUES BELOW THIS AD
ALSO READ | Is tomato the 'mother' of potato? What a new study reveals
The study also suggested that replacing fried potatoes with boiled, baked, or mashed ones may help reduce the risk of this long-term illness.
But what does the study actually say? How are fries linked to diabetes, and how many fries are considered too much?
Let's find out:
What does the research say?
A new study published in the BMJ journal on Wednesday has found that eating three servings of French fries a week could raise the chances of developing type 2 diabetes by 20 per cent.
According to the findings, people who consume fries five times a week may face a 27 per cent higher risk of the condition.
Notably, the researchers studied health data from over 205,000 medical professionals in the United States. These participants filled out detailed food questionnaires across nearly 40 years.
French fries are undoubtedly one of the most popular snacks around the world. Pixabay/Representational Image
Among those who ate potatoes, the researchers examined who went on to develop type 2 diabetes, a condition that causes blood sugar levels to remain high over time.
Diet-related surveys were repeated several times during the study period. During follow-ups, over 22,000 cases of type 2 diabetes were recorded, according to BBC.
'The risks associated with potato intake varied by cooking method,' the researchers said. 'The association between higher potato intake and increased T2D risk is primarily driven by intake of French fries.'
STORY CONTINUES BELOW THIS AD
The study was led by Seyed Mohammad Mousavi, a public health researcher at Harvard University, along with a team of international scientists. They looked into how eating potatoes might affect the chances of developing type 2 diabetes.
Candida Rebello, who heads the nutrition and chronic disease programme at Louisiana State University and was not part of the study, told NBC News, 'When you fry the potatoes, the energy content — calories — increases because of the fat they absorb. If you eat many servings of French fries, it predisposes [people] to weight gain.'
ALSO READ | Rare pneumonia-like illness kills 3 in New York City: What is Legionnaires' disease? Is it deadly?
How many fries is too many?
The study found that eating French fries three times a week could raise the risk of type 2 diabetes by 20 per cent. Meanwhile, eating baked, boiled, or mashed potatoes with the same frequency increased the risk by only 5 per cent.
According to the researchers, 'The high starch content of potatoes, leading to a high glycemic index and load, combined with possible loss of nutrients and possible health risks resulting from various cooking methods, could contribute to adverse health outcomes.'
Unlike boiled or baked potatoes, French fries are deep-fried in oils that often contain trans or saturated fats. The way the body processes these fats may lead to insulin resistance, where cells stop responding to insulin, the hormone responsible for managing blood sugar levels.
STORY CONTINUES BELOW THIS AD
The study suggested that replacing fried potatoes with boiled, baked, or mashed ones may help reduce the risk of this long-term illness. Pixabay/Representational Image
Eating fried foods regularly can also cause weight gain and inflammation, both of which are risk factors for type 2 diabetes.
The researchers also noted that swapping three weekly servings of potatoes with whole grains helped reduce the risk of type 2 diabetes by 8 per cent.
On the other hand, replacing potatoes with white rice was also found to raise the risk, as white rice showed a stronger link to type 2 diabetes than both potatoes and fries.
Seyed Mohammad Mousavi said that making fries at home using healthier oils might be a better option than eating fast-food fries.
He also suggested that replacing potatoes with whole grains such as farro, whole-grain bread, or pasta could have a more positive effect.
The researchers concluded, 'With their relatively low environmental impact and their health impact, potatoes can be part of a healthy and sustainable diet, though whole grains should remain a priority.'
With inputs from agencies
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
News18
4 hours ago
- News18
For people with ADHD, medication can reduce risk of accidents, crime, suicide
Sydney, Aug 16 (The Conversation) Attention-deficit hyperactivity disorder (ADHD) is a neurodevelopmental condition that affects around 7 per cent of children and 2.5 per cent of adults. ADHD causes difficulties with holding and sustaining attention over periods of time. People with ADHD also experience hyperactivity and high levels of impulsiveness and arousal. This can make it difficult to plan, coordinate and remain engaged in tasks. ADHD is linked to problems at work, school and home, and to higher rates of mental illnesses such as anxiety. It's also associated with higher rates of long-term harms. Stimulant medication, such as methylphenidate and dextroamphetamine, is the most common treatment for managing ADHD symptoms. Most people with ADHD will respond to at least one ADHD medication. But rising rates of prescriptions in recent years have prompted concern for their effectiveness and safety. New research published today in the journal BMJ points to additional longer-term benefits. It found that people with ADHD who took medication were less likely to have suicidal behaviours, transport accidents, issues with substance misuse, or be convicted of a crime. What did the study do? The study tracked 148,581 people who received a new diagnosis of ADHD between 2007 and 2018. The authors used population-based data from Swedish national registers, including everyone aged six to 64 who was newly diagnosed with ADHD. The average age was 17.4 years, and 41per cent were female. Participants either started or did not start medication within three months of their ADHD diagnosis. The authors examined the effects of drug treatment for ADHD on five critical outcomes: suicidal behaviours, substance misuse, accidental injuries, transport accidents and committing crimes. They looked at both first-time and recurrent events. This study used a method that uses data from health records or registries to mimic the design of a randomised controlled trial, in an attempt to reduce bias. The researchers accounted for age, education, other mental and physical illnesses, prior history and use of other drugs to account for factors that may influence results. What did they find? Within three months of receiving an ADHD diagnosis, 84,282 (56.7 per cent) of people had started drug treatment for ADHD. Methylphenidate was the most commonly prescribed drug, accounting for 88.4 per cent of prescriptions. Drug treatment for ADHD was associated with reduced rates of a first occurrence for four out of the five outcomes: a 17 per cent reduction for suicidal behaviours, 15 per cent for substance misuse, 12 per cent for transport accidents and 13 per cent for committing a crime. When the researchers looked at people with recurrent events, the rate reductions associated with ADHD medication were seen for all five outcomes (including accidental injury). The effect of medication was particularly strong when someone had a history of these events happening frequently. This means those with the most severe symptoms may benefit most. Stimulant drugs were associated with lower rates of all five outcomes compared with non-stimulant drugs. It's likely these benefits are associated with improvements in attention, impulsivity and hyperactivity. People may be less likely to be distracted while driving, to self-medicate and show impacts from other mental health challenges. What didn't the study do? The large sample size, use of national linked registers and sophisticated design give greater confidence that these findings are due to medication use and not due to other factors. But the study was not able to examine medication dosages or track whether people reliably took their medication as prescribed. It also had no way to track the severity of ADHD symptoms. This means it can't tell us if this helped most people or just some people with severe symptoms. We know that ADHD medication helps most people, but it is not effective for everyone. So, we still need to understand why some people don't benefit from ADHD medication, and what other treatments might also be helpful. Finally, even though the study was rigorous in its design and adjusted for many factors, we can't rule out that other unaccounted factors could be associated with these effects. As prescribing increases, the size of the benefit decreases. A second study, published in June, used the same Swedish national registers and self-controlled case series design. This study also concluded that ADHD medication was associated with reduced risks for self-harm, accidental injuries, transport accidents and committing a crime. However, this study also showed that as prescribing rates increased nearly fivefold between 2006 and 2020, the size of the observed benefits of ADHD medications reduced. While remaining significant, the size of the associations between ADHD medication use and lower risks of unintentional injury, traffic crashes, and crime weakened over this time. This could mean people who are less likely to need ADHD medications are now receiving them. What are the impacts for patients and policymakers? People need to know that if ADHD medications are helpful for them or their children, they might also improve many other areas of life. These findings can also give governments confidence that their recent initiatives and efforts to increase access to ADHD support and treatment may have positive downstream impacts on broader social outcomes. But medications aren't the only ADHD treatment. Medication should only represent one part of a solution, with other psychological supports for managing emotional regulation, executive and organisational skills and problem-solving also beneficial. Psychological therapies are effective and can be used in combination with, or separately from, medication. top videos View all Yet research shows drug treatments are relied on more frequently in more disadvantaged communities, where it's harder to access psychological supports. Policymakers need to ensure medication does not become the only treatment people have access to. People with suspected ADHD need a high-quality diagnostic assessment to ensure they get the right diagnosis and the treatment most suitable for them. (The Conversation) SKS GRS GRS (This story has not been edited by News18 staff and is published from a syndicated news agency feed - PTI) view comments First Published: August 16, 2025, 12:45 IST News agency-feeds For people with ADHD, medication can reduce risk of accidents, crime, suicide Disclaimer: Comments reflect users' views, not News18's. Please keep discussions respectful and constructive. Abusive, defamatory, or illegal comments will be removed. News18 may disable any comment at its discretion. By posting, you agree to our Terms of Use and Privacy Policy.
Time of India
15 hours ago
- Time of India
India–Australia bioinnovation corridor launches cross border tech accelerator
The Bangalore Bioinnovation Centre (BBC) and La Trobe University (LTU), Australia, have launched the Ind–Aus Launchpad Programme, a cross-border accelerator designed to fast-track high-potential biotech, digital health, and sustainable technology startups for global initiative builds on the Bioinnovation Exchange Corridor, established under a September 2024 MoU between the State of Victoria and the State of Karnataka. Supported by the Department of IT, BT and S&T, Government of Karnataka, and the Victorian Government, the corridor integrates the startup ecosystems of Bengaluru and Melbourne, enabling joint R&D, advanced prototyping, and rapid commercialization in sectors including digital health, sustainable agriculture, precision medicine, and environmental resilience. The programme's first cohort of 11 Indian startups underwent an intensive 12-week pre-accelerator at BBC, combining shared lab and prototyping facilities, market access simulations, IP advisory services, and advanced TRL (Technology Readiness Level) assessments. Startups were also evaluated on Commercialization Readiness Level (CRL) and Manufacturing Readiness Level (MRL) to ensure technology viability and scalability. Following this process, three startups were selected for a fully sponsored immersion programme at LTU's Bio Innovation Hub in Melbourne: 1. Microbeworks Scientific – Developing bioengineered microbial dyes to replace toxic synthetic dyes in textiles, with potential to reduce water contamination by up to 90%. 2. HornetBiologicals – Using RT-PCR and microarray-based genetic screening to improve livestock breeding productivity by over 30%. 3. IMRobonix – Creator of SurgiKot, India's first robotic handheld device for precision-driven minimally invasive surgeries, integrating AI-guided navigation. The Melbourne immersion includes co-location with LTU researchers, regulatory readiness workshops, investor roundtables, and product-market feasibility studies for Australia and global markets. Over the next phase, the programme will add a one-month onsite immersion, 12-month virtual residency, and cross-border co-innovation sprints for startups from both India and Australia. 'The Ind–Aus. Launchpad operationalizes a global innovation pipeline — giving startups real-world access to R&D infrastructure, regulatory expertise, and market intelligence,' said Dr Mohamed Adil A.A, Managing Director, BBC. 'This is a two-way bridge between two leading innovation economies, designed to deliver deep-tech and digital health solutions with global relevance,' added Professor Theo Farrell, Vice-Chancellor, La Trobe University. With global biotech expected to reach USD 3.88 trillion by 2030 (Grand View Research), and India projected to become a USD 150 billion bioeconomy by 2025, the corridor exemplifies how international innovation diplomacy can accelerate the translation of research into market-ready technologies. By linking India's high-growth startup ecosystem with Australia's advanced research infrastructure, the Ind–Aus. Launchpad positions both economies to address shared challenges in health, sustainability, and technology-led growth.
Hindustan Times
a day ago
- Hindustan Times
Love French fries and potato chips? Study reveals eating them thrice a week increases diabetes risk by 20%
Potatoes have quite the fan following when it comes to snacks, with big headliners being potato chips and French fries. Being versatile, potatoes are also a staple in lunch and dinner in different forms, such as mashed potatoes paired with veggies. To understand how potatoes might affect health, especially the risk of developing type 2 diabetes, a recent study published in the British Medical Journal aimed to examine whether different ways of eating potatoes, fried, baked, boiled, or mashed, made any difference. Chips may be pleasant for your taste buds, but this addictive food may be slowly shortening your lifespan!(Shutterstock) ALSO READ: Can people with type 2 diabetes eat mango? Study says yes, if done this way What did the study find? French fries are very common. Every fast food chain includes it in their meal packs. (Shutterstock) Let's go one by one through each of the potato cooking styles and how they may increase diabetes risks. Baked, boiled, and mashed ways of eating potatoes have the lowest risk factor compared to fried. The study's findings rounded up the likelihood to only a 5% increase. But the most concerning are the fried potatoes, both French fries and potato chips, which, when eaten three times a week, increase type 2 diabetes risk by a whopping 20%, and if eaten five times a week, by 27%. The study also recommended that if you reduce your potato intake, the likelihood of getting diabetes goes down. The researchers suggested swapping potatoes with better carbs like whole grains, including brown rice and wholemeal pasta. This reduced the risk by 8 per cent. Specifically with French fries, if you eliminate them, the risk drops by 19 per cent. But again, the researchers cautioned against the kind of carb you are switching to, as white rice didn't help much, and instead backfires and defeats the purpose of the entire swap, as white rice is high on the glycemic index and increases the risk of sugar spike after eating. What does it mean? Children are one of the vulnerable groups because they are frequently given potato chips as snacks.(Shutterstock) So what are the implications of the study's findings? On a regular basis, the fried format of potato is more popular, whether it's parents pacifying their kids with a bag of chips or a burnt-out employee ordering takeaway fast food meal packs, which include staples like fried potatoes and burgers. They are so common that the consumption of fried potatoes is seen in every other household. It is alarming, given how the study associated the consumption with diabetes risk by almost twenty per cent. But how you prepare potatoes, whether by baking or boiling, can still make them relatively healthier. However, since potatoes are a heavy carb and high on the glycemic index, the researchers reiterated the importance of choosing smarter carbs instead. The quality of carbs matters for both energy levels and preventing blood sugar spikes. Note to readers: This article is for informational purposes only and not a substitute for professional medical advice. Always seek the advice of your doctor with any questions about a medical condition.
